Dom Glavach and Roger Davy will discuss "Cybersecurity Threats and Risks to Life Sciences Companies"
Cybersecurity Threats and Risks to Life Sciences Companies
Life sciences companies are leveraging digitalization, new and evolving technologies, and third-party providers to boost innovation, quality, and speed.
These compelling advances also introduce cybersecurity vulnerabilities. Recent failures within companies and their third-party providers have led to significant and mounting harms. As an essential constituent of technology and business strategy, threats and risks must be evaluated and managed.
Understanding current and emerging cybersecurity threats and risks and how to deal with them is critical to the protection of intellectual properties, data, and patient privacy, and to continuous regulatory compliance.
This discussion will include:
- Examples of current and emerging cybersecurity threats
- What to expect from third-party providers
- How to ensure privacy and cybersecurity compliance
- What your life sciences company can do to minimize risk
About the Presenters:
Project Management Lead Roger has 18 years of Operations and IT Project Management experience in both consulting and industry roles in the pharmaceuticals, bio-tech, engineering and semiconductor industries. Working with both small and large Life Sciences firms, he has managed successful projects to address operations, quality, compliance and regulatory challenges
Chief Security Officer and Chief Security Strategist, CyberSN Mr. Glavach has more than 20 years of cybersecurity experience in commercial industries and as a contractor for the Department of Defense and intelligence communities. In this executive role, he is responsible for leading the company’s information security strategy, policy, IT operations, security engineering, security operations, data privacy, and cyber threat detection.